Milena Stachelska

Dr. Milena Stachelska


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MSMilena Stachelska
Milena Stachelska
PKPiotr Karpiński
Piotr Karpiński
BKBartosz Kruszewski
Bartosz Kruszewski
Dietary flavonoids are emerging as multifunctional bioactive compounds with significant implications for the prevention and management of chronic diseases. Integrating the latest experimental, clinical, and epidemiological evidence, this review provides a comprehensive synthesis of flavonoid classification, chemistry, dietary sources, and bioavailability, with special attention to their structural diversity and core mechanisms. Mechanistic advances related to antioxidant, anti-inflammatory, antimicrobial, anti-obesity, neuroprotective, cardioprotective, and anticancer activities are highlighted, focusing on the modulation of critical cellular pathways such as PI3K/Akt/mTOR, NF-κB, and AMPK. Evidence from in vitro and in vivo models, supported by clinical data, demonstrates flavonoids’ capacity to regulate oxidative stress, inflammation, metabolic syndrome, adipogenesis, cell proliferation, apoptosis, autophagy, and angiogenesis. An inverse correlation between flavonoid-rich dietary patterns and the risk of obesity, cancer, cardiovascular, and neurodegenerative diseases is substantiated. However, translational challenges persist, including bioavailability and the optimization of delivery strategies. In conclusion, a varied dietary intake of flavonoids constitutes a scientifically grounded approach to non-communicable disease prevention, though further research is warranted to refine clinical applications and elucidate molecular mechanisms.

24 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMilena Stachelska
Milena Stachelska
PKPiotr Karpiński
Piotr Karpiński
BKBartosz Kruszewski
Bartosz Kruszewski
Background/Objectives: There is scattered information in the scientific literature regarding the characterization of probiotic bacteria found in fermented milk beverages and the beneficial effects of probiotic bacteria on human health. Our objective was to gather the available information on the use of probiotic bacteria in the prevention of civilization diseases, with a special focus on the prevention of obesity, diabetes, and cancer. Methods: We carried out a literature review including the following keywords, either individually or collectively: lactic acid bacteria; probiotic bacteria; obesity; lactose intolerance; diabetes; cancer protection; civilization diseases; intestinal microbiota; intestinal pathogens. Results: This review summarizes the current state of knowledge on the use of probiotic bacteria in the prevention of civilization diseases. Probiotic bacteria are a set of living microorganisms that, when administered in adequate amounts, exert a beneficial effect on the health of the host and allow for the renewal of the correct quantitative and qualitative composition of the microbiota. Probiotic bacteria favorably modify the composition of the intestinal microbiota, inhibit the development of intestinal pathogens, prevent constipation, strengthen the immune system, and reduce symptoms of lactose intolerance. As fermented milk beverages are an excellent source of probiotic bacteria, their regular consumption can be a strong point in the prevention of various types of civilization diseases. Conclusions: The presence of lactic acid bacteria, including probiotic bacteria in fermented milk beverages, reduces the incidence of obesity and diabetes and serves as a tool in the prevention of cancer diseases.

29 March 2024 in Molecules
Verified
Journal Article
Open access
PDF file
MSMilena Stachelska
Milena Stachelska
Adam EkielskiAdam Ekielski
Adam Ekielski
PKPiotr Karpiński
Piotr Karpiński
TŻTomasz Żelaziński
Tomasz Żelaziński
BKBartosz Kruszewski
Bartosz Kruszewski
Lactic acid bacteria (LAB) play an important role in the ripening of cheeses and contribute to the development of the desired profile of aroma and flavor compounds. Therefore, it is very important to monitor the dynamics of bacterial proliferation in order to obtain an accurate and reliable number of their cells at each stage of cheese ripening. This work aimed to identify and conduct a quantitative assessment of the selected species of autochthonous lactic acid bacteria from raw cow’s milk cheese by the development of primers and probe pairs based on the uniqueness of the genetic determinants with which the target microorganisms can be identified. For that purpose, we applied real-time quantitative PCR (qPCR) protocols to quantify Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus, and Lactococcus lactis subsp. cremoris cells in cheese directly after production and over three-month and six-month ripening periods. While L. lactis subsp. cremoris shows good acidification ability and the ability to produce antimicrobial compounds, L. delbrueckii subsp. bulgaricus has good proteolytic ability and produces exo-polysaccharides, and S. thermophilus takes part in the formation of the diacetyl flavor compound by metabolizing citrate to develop aroma, they all play an important role in the cheese ripening. The proposed qPCR protocols are very sensitive and reliable methods for a precise enumeration of L. delbrueckii subsp. bulgaricus, S. thermophilus, and L. lactis subsp. cremoris in cheese samples.

8 July 2026 in Foods
Verified
Journal Article
Open access
PDF file
MSMilena Stachelska
Milena Stachelska
MBMariusz Banach
Mariusz Banach
PKPiotr Karpiński
Piotr Karpiński
BKBartosz Kruszewski
Bartosz Kruszewski
Artisanal raw-milk cheese represents a complex biochemical ecosystem where the indigenous microbiota acts as the primary driver of the volatile profile. This study utilizes an innovative synchronized biological relay model to decipher the mechanistic interplay between the successional dynamics of indigenous lactic acid bacteria (LAB) and the temporal evolution of the volatile metabolome over a 10-week maturation period of an artisanal cow-milk cheese. Utilizing a culture-dependent approach focused on the quantitative enumeration of broad morpho-physiological groups—without species-level identification—integrated with HS-SPME/GC-MS, we characterized the precise shifts from early-stage lactic cocci to dominant rod-shaped lactobacilli. Initial populations at Week 0 consisted of 8.2 log CFU/g of cocci and 4.1 log CFU/g of rod-shaped LAB. Lactic cocci peaked at Week 2 (8.5 log CFU/g) before undergoing mass autolysis down to 7.1 log CFU/g by Week 4, releasing intracellular enzymes that catalyzed a 900% surge in total esters and a 215% increase in volatile alcohols. Concurrently, rod-shaped LAB proliferated to a maximum of 8.6 log CFU/g at Week 6, directly correlating with a 125% increase in total carboxylic acids, prominently driven by a 750% accumulation of hexanoic acid. The late-phase maturation (Weeks 8–10) established a technological equilibrium: volatile sulfur compounds collapsed by over 90% within the first two weeks, initial transient lactones were replaced by a 1200% late-stage increase in dodecalactone, and matrix-sequestered dietary terpenes were liberated via an 8-fold (700%) increase at Week 8. This study introduces an innovative, statistically validated volatilomic framework that equips the dairy sector with an advanced metabolomic tool for rigorous product authentication and targeted flavor optimization, thereby establishing a scientific baseline for the reproducible production of premium, organoleptically superior artisanal cheeses.